Vimarsana
Biggest News Aggregation in the World

Page 2 - Pharma Intelligence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Intelligence Today - Breaking & Trending Today

CAR-T News | Latest News - Vimarsana News

CAR-T News | Latest News

Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer

Ipsos: Appointment of Dr Bonnie Bain as Global Head of Healthcare - Vimarsana News

Ipsos: Appointment of Dr Bonnie Bain as Global Head of Healthcare

Paris, September11, 2023 - I am pleased to announce that DrBonnie Bain, PhD has been appointed Global Head of Healthcare and will join us on 11th ...

40% of Global AI Companies Focus on Early Drug Development while AI-Powered Startups Reshape the Future of Drug Discovery - Vimarsana News

40% of Global AI Companies Focus on Early Drug Development while AI-Powered Startups Reshape the Future of Drug Discovery

40% of Global AI Companies Focus on Early Drug Development while AI-Powered Startups Reshape the Future of Drug DiscoveryNew industry report from Deep Pharma Intelligence has redefined the Global State of AI in Drug DiscoveryAugust 16, 2023 - London, UK: The largest profiling of the global AI in the Drug Discovery i...

Global State of AI in Drug Discovery Defined New Industry Report & IT-Platform Present Most Comprehensive Overview of AI in Pharma - Vimarsana News

Global State of AI in Drug Discovery Defined New Industry Report & IT-Platform Present Most Comprehensive Overview of AI in Pharma

Global State of AI in Drug Discovery DefinedNew Industry Report & IT-Platform Present Most Comprehensive Overview of AI in Pharma10 August 2023www.deep-pharma.tech/ai-platform  August 10, 2023 - London, UK: The largest profiling of the global AI in the Drug Discovery industry made to date has been released...

Astellas to accelerate ocular disease therapies via $5.9b acquisition - Vimarsana News

Astellas to accelerate ocular disease therapies via $5.9b acquisition

A $5.9 billion acquisition of biotech Iveric Bio by Astellas is set to accelerate development of treatments for blinding retinal diseases.